Insider Buys 2,900 Shares of Ascendis Pharma – A Bullish Signal for Investors
Insider buying fuels optimism for Ascendis Pharma: executive Biénaime tops 2,900 shares, boosting bullish sentiment and hinting at a future rally.
3 minutes to read
ASCENDIS PHARMA a/S